{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T18:15:06Z","timestamp":1772302506878,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>HIV pre-exposure prophylaxis (HIV-PrEP) is an effective method for preventing HIV transmission, and it is recommended in several international guidelines. Perceptions and knowledge about HIV-PrEP prescription among healthcare providers have not been investigated in Thailand where HIV-PrEP is a novel healthcare topic. The objective of study was to determine healthcare providers\u2019 attitudes towards, knowledge about, and confidence to prescribe HIV-PrEP in Thailand.<\/jats:p>\n            <jats:p>A questionnaire was administered to Thai healthcare providers during May 1, 2017 to September 5, 2018.<\/jats:p>\n            <jats:p>Of the 500 questionnaires that were distributed, 460 were returned (92%). Respondents included 336 physicians (48 infectious disease [ID] physicians, 288 non-ID physicians) and 124 non-physicians (70 nurses, 35 pharmacists, and 19 others). Eighty one percent of respondents had a positive attitude towards HIV-PrEP. Multivariate analysis revealed being a non-ID physician, having prior knowledge about HIV-PrEP, believing that HIV-PrEP can reduce the number of new patients, and believing that HIV-PrEP is not associated with a higher incidence of other sexually transmitted infections were all factors significantly associated with having a positive attitude towards HIV-PrEP. The issue of most concern to respondents who had a negative attitude toward HIV-PrEP was poor patient adherence to antiviral medications. Only 57% of respondents had confidence to prescribe HIV-PrEP. Factors associated with confidence to prescribe HIV-PrEP included being an ID physician, believing that HIV-PrEP can reduce the number of new patients, believing in the safety of antiviral medications, and believing that HIV-PrEP is not associated with increased development of HIV drug resistance. The results of HIV-PrEP knowledge testing (8 questions) were categorized into good score (\u22657\/8) and fair score (\u22646\/8). Fifty five percent of participants had a good score result. Using multivariate analysis, the factors associated with a good score result were ID physician, having HIV-PrEP prescription experience, and believing that HIV-PrEP can reduce the number of new patients.<\/jats:p>\n            <jats:p>Most Thai healthcare providers (81%) reported having a positive attitude towards HIV-PrEP. Successful HIV-PrEP implementation in Thailand will require steps to mitigate the described barriers, and training for healthcare providers, which will strengthen knowledge and improve both experience with and confidence to prescribe HIV-PrEP.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000028120","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T13:05:58Z","timestamp":1639141558000},"page":"e28120","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Attitudes towards, knowledge about, and confidence to prescribe antiretroviral pre-exposure prophylaxis among healthcare providers in Thailand"],"prefix":"10.1097","volume":"100","author":[{"given":"Pruettichai","family":"Wisutep","sequence":"first","affiliation":[{"name":"Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"},{"name":"School of Medicine, Institute of Medicine, Suranaree University of Technologgy, Nakornratchasima, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1486-5550","authenticated-orcid":false,"given":"Rujipas","family":"Sirijatuphat","sequence":"additional","affiliation":[{"name":"Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oranich","family":"Navanukroh","sequence":"additional","affiliation":[{"name":"Department of Preventive and Social Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phatharajit","family":"Phatharodom","sequence":"additional","affiliation":[{"name":"Department of Preventive and Social Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peerawong","family":"Werarak","sequence":"additional","affiliation":[{"name":"Department of Preventive and Social Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winai","family":"Rattanasuwan","sequence":"additional","affiliation":[{"name":"Department of Preventive and Social Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,10]]},"reference":[{"key":"R1-20250504","first-page":"507","article-title":"Update on acquired immune deficiency syndrome (AIDS)\u2014United States","volume":"31","year":"1982","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.2016.5148","article-title":"Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy","volume":"316","author":"Rodger","year":"2016","journal-title":"JAMA"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N Engl J Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1097\/QAD.0000000000001145","article-title":"Effectiveness and safety of oral HIV preexposure prophylaxis for all populations","volume":"30","author":"Fonner","year":"2016","journal-title":"AIDS"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"HIV antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/09540121.2012.748871","article-title":"Facilitators and barriers to medication adherence in an HIV prevention study among men who have sex with men in the iPrEx study in Chiang Mai, Thailand","volume":"25","author":"Tangmunkongvorakul","year":"2013","journal-title":"AIDS Care"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/apc.2012.0030","article-title":"Evolution of Massachusetts physician attitudes, knowledge, and experience regarding the use of antiretrovirals for HIV prevention","volume":"26","author":"White","year":"2012","journal-title":"AIDS Patient Care STDS"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"e4511","DOI":"10.1097\/MD.0000000000004511","article-title":"Knowledge, attitudes, and beliefs about HIV pre-exposure prophylaxis among US Air Force Health Care Providers","volume":"95","author":"Hakre","year":"2016","journal-title":"Medicine"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s10461-015-0996-z","article-title":"Knowledge is power! Increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP","volume":"19","author":"Blumenthal","year":"2015","journal-title":"AIDS Behav"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/apc.2011.0283","article-title":"Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study","volume":"26","author":"Brooks","year":"2012","journal-title":"AIDS Patient Care and STDS"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/apc.2010.0222","article-title":"Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings","volume":"25","author":"Myers","year":"2011","journal-title":"AIDS Patient Care and STDs"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"12381","DOI":"10.1073\/pnas.1006061107","article-title":"HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis","volume":"107","author":"Supervie","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11904-007-0024-7","article-title":"Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies","volume":"4","author":"Eaton","year":"2007","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1758-2652-13-24","article-title":"Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities","volume":"13","author":"Kim","year":"2010","journal-title":"J Int AIDS Soc"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"e0173057","DOI":"10.1371\/journal.pone.0173057","article-title":"Awareness and attitudes of prescribing pre-exposure prophylaxis for HIV prevention among medical providers in Guatemala: Implications for country-wide implementation","volume":"12","author":"Ross","year":"2017","journal-title":"PLoS One"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s15010-015-0850-2","article-title":"HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans","volume":"44","author":"Spinner","year":"2016","journal-title":"Infection"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2018.1917","article-title":"HIV preexposure prophylaxis: a review","volume":"319","author":"Riddell","year":"2018","journal-title":"JAMA"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1 infection","volume":"373","author":"Molina","year":"2015","journal-title":"N Engl J Med"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1471-2458-10-401","article-title":"Reviewing the evidence on effectiveness and cost-effectiveness of HIV prevention strategies in Thailand","volume":"10","author":"Pattanaphesaj","year":"2010","journal-title":"BMC Public Health"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:08:31Z","timestamp":1746335311000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000028120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,10]]},"references-count":22,"journal-issue":{"issue":"49","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000028120","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,10]]},"assertion":[{"value":"2021-04-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}